Get the tools used by (smart)2 investors.

Net Interest Expenses for Insulet Corporation

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

PODD: Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform ...

258.75 USD
Price
USD
Fair Value
Upside
160.19 - 289.46
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Insulet Corporation's Net Interest Expenses:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 2024-60 M-40 M-20 M

Performance Summary

    How does Insulet's Net Interest Expenses benchmark against competitors?

    Hide this widget

    Metric Usage: Net Interest Expenses

    Hide this widget
    net_interest_exp
    Slug
    number
    Datatype
    text
    Format
    current
    Default Period
    FY, Q, LTM, YTD
    Periods Supported
    Free
    Plan

    To view the full list of supported financial metrics please see Complete Metrics Listing.

    Similar Metrics

    Hide this widget

    Metrics similar to Net Interest Expenses in the financials category include:

    View Full List

    Search for metric or datapoint

    Net Interest Expenses

    This item represents the interest expense net of interest income.

    Definition of Net Interest Expenses

    Hide this widget

    Insulet reported net interest expenses of -3.2 M for the latest twelve months ending December 31, 2024 on its income statement.

    The tables below summarizes Insulet’s Net Interest Expenses and common size over the last five years:

    Fiscal YearNet Interest ExpensesRevenue% Revenue
    2020-12-31-45.1 M904.4 M−5.0%
    2021-12-31-61.2 M1.099 B−5.6%
    2022-12-31-26.7 M1.305 B−2.0%
    2023-12-31-7.6 M1.697 B−0.4%
    2024-12-31-3.2 M2.072 B−0.2%

    The tables below summarizes Insulet’s Net Interest Expenses and common size over the last four quarters:

    Quarter EndingNet Interest ExpensesRevenue% Revenue
    2024-03-31-1.3 M441.7 M−0.3%
    2024-06-30-1.7 M488.5 M−0.3%
    2024-09-30-1.8 M543.9 M−0.3%
    2024-12-311.6 M597.5 M0.3%

    Click the link below to download a spreadsheet with an example Net Interest Expenses calculation for Insulet Corporation below:

    Sector Benchmark Analysis

    Sector
    Industry Group
    Industry
    Hide this widget
    -323.6 M-228.6 M-133.6 M37.634 M0400800

    The chart above depicts the distribution of net interest expenses for companies operating in the Healthcare sector in the Developed economic region. Over 2,380 companies were considered in this analysis, and 2,290 had meaningful values. The average net interest expenses of companies in the sector is -7.422 M with a standard deviation of 34.21 M.

    Insulet Corporation's Net Interest Expenses of -3.2 M ranks in the 20.0% percentile for the sector. The following table provides additional summary stats:

    Net Interest Expenses In The Healthcare Sector
    Economic Risk RegionDeveloped
    Total Constituents2,386
    Included Constituents2,290
    Min-323.2 M
    Max34.742 M
    Median-33.672 K
    Mean-7.422 M
    Standard Deviation34.21 M

    You can find companies with similar net interest expenses using this stock screener.

    All rights reserved. Terms Of Use